Literature DB >> 9186806

Kinetics of immunological parameters in patients with malignant melanoma treated with hyperthermic isolated limb perfusion.

J Nakayama1, T Nakao, T Mashino, S Nagae, Y Hori, H Mayumi, R Tominaga, H Yasui, K Matsuda, S Takahashi.   

Abstract

Kinetics of immunological parameters such as natural killer (NK) cell activity and tritium-thymidine uptake rate of T lymphocytes by phytohemagglutinin stimulation were investigated using peripheral leukocyte fractions of melanoma patients treated with hyperthermic isolated limb perfusion (HILP). Also, serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1) were quantified during and after HILP. It was found that NK cell activity was augmented during HILP, and T lymphocyte function was stimulated 24 h and 1 week after HILP with statistical significance. NK cell activities in the cells isolated from perfused and non-perfused circulations were equally augmented during HILP in two patients examined. Serum concentrations of sICAM-1 in the patients who received HILP also increased 24 h or even 1 week after HILP. The stimulation of these immune competent cells and upregulation of sICAM-1 by HILP were independent of the stages of melanoma patients at the time of HILP or the doses of agents which were used for the infusion during HILP. The origin of cells which shed sICAM-1 into the serum of the patients who received HILP remains to be further investigated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186806     DOI: 10.1016/s0923-1811(96)00587-7

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  5 in total

Review 1.  Exercising in environmental extremes : a greater threat to immune function?

Authors:  Neil P Walsh; Martin Whitham
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 2.  Isolated limb infusion as a model to test new agents to treat metastatic melanoma.

Authors:  Michael E Lidsky; Paul J Speicher; Betty Jiang; Masahito Tsutsui; Douglas S Tyler
Journal:  J Surg Oncol       Date:  2013-11-20       Impact factor: 3.454

Review 3.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

4.  Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma.

Authors:  Betty S Jiang; Georgia M Beasley; Paul J Speicher; Paul J Mosca; Michael A Morse; Brent Hanks; April Salama; Douglas S Tyler
Journal:  Ann Surg Oncol       Date:  2014-04-04       Impact factor: 5.344

5.  [BSD2000 deep hyperthermia combined with chemotherapy of PT regimen in patients with non-small cell lung cancer].

Authors:  Mengxiang Yang; Jun Zhao; Yanwen Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.